This inventor holds 1 USPTO granted patent. Top assignees: Het Nederlands Kanker Instituut, Introgene B.v.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Hendricus Gerhard Van Luenen: Innovator in Genetic Engineering
Introduction
Hendricus Gerhard Van Luenen is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of genetic engineering, particularly through his innovative patent that enhances the techniques used for producing recombinant nucleic acid molecules and cells. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Van Luenen holds a patent titled "Vectors and methods for providing cells with additional nucleic acid." This invention provides novel elements aimed at improving genetic engineering techniques. The essential elements derived from transposons, specifically from the Tc/Mariner superfamily, enable the integration of desired nucleic acid material into the genome of a host cell. The patent highlights the essential elements of Tc1 that facilitate the excision and pasting of nucleic acid material, along with the relevant transposase activity.
Career Highlights
Throughout his career, Van Luenen has worked with esteemed organizations such as Het Nederlands Kanker Instituut and Introgene B.V. His experience in these institutions has allowed him to collaborate with leading experts in the field of genetic research and biotechnology.
Collaborations
Some of his notable coworkers include Ronald Hans Plasterk and Domenico Valerio. Their collaborative efforts have contributed to advancements in genetic engineering and related fields.
Conclusion
Hendricus Gerhard Van Luenen's innovative work in genetic engineering, particularly through his patent, showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact the future of genetic research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile